Clinical trial
Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial): a Multi-centre, Type 1 Hybrid Effectiveness-implementation, Stepped-wedge, Randomised Controlled Trial
NCT06794320 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial): a Multi-centre, Type 1 Hybrid Effectiveness-implementation, Stepped-wedge, Randomised Controlled Trial
- Lead sponsor
- The University of Hong Kong
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 1, 2025
- Completion date
- December 31, 2026
- Enrollment
- 648 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neutropenic fever